MedKoo Cat#: 596893 | Name: Ascorbic acid, rutoside drug combination

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ascorbic acid, rutoside drug combination is used in treatment of diabetic retinopathy.

Chemical Structure

Ascorbic acid, rutoside drug combination
Ascorbic acid, rutoside drug combination
CAS#8067-12-7

Theoretical Analysis

MedKoo Cat#: 596893

Name: Ascorbic acid, rutoside drug combination

CAS#: 8067-12-7

Chemical Formula: C33H38O22

Exact Mass: 786.1855

Molecular Weight: 786.64

Elemental Analysis: C, 50.39; H, 4.87; O, 44.74

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Ascorbic acid, rutoside drug combination; Ruta C 60; Rutascorbin; Cerutin; Rutinoscorbin;
IUPAC/Chemical Name
(R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one compound with 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one (1:1)
InChi Key
USMZEYPOTJAYPT-LRROQMAJSA-N
InChi Code
InChI=1S/C27H30O16.C6H8O6/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9;7-1-2(8)5-3(9)4(10)6(11)12-5/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3;2,5,7-10H,1H2/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-;2-,5+/m00/s1
SMILES Code
C[C@@H]1O[C@H]([C@@H]([C@@H]([C@H]1O)O)O)OC[C@H]2O[C@H]([C@@H]([C@H]([C@@H]2O)O)O)OC3=C(c4cc(O)c(O)cc4)Oc5c(C3=O)c(O)cc(O)c5.OC[C@@H]([C@H]6OC(C(O)=C6O)=O)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 786.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Vasylyshyna E. Influence of freezing and storing cherry fruit on its nutritional value. Acta Sci Pol Technol Aliment. 2016 Apr-Jun;15(2):145-150. doi: 10.17306/J.AFS.2016.2.14. PubMed PMID: 28071004. 2: Fábián G, Rumi G, Sámik J, Magyarlaki T, Szöke B, Nagy J. [Chronic IgM mesangioproliferative glomerulonephritis]. Orv Hetil. 1995 Nov 19;136(47):2573-6. Hungarian. PubMed PMID: 8532323. 3: Frolov VM, Peresadin NA, Pinskiĭ LL, Korobka IuN. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents]. Lik Sprava. 1992 Nov-Dec;(11-12):102-4. Russian. PubMed PMID: 1292201. 4: Gal'perin EI, Tatishvili GG, Akhaladze GG, Sakevarashvili GR, Nasirov FN, Aref'ev AE. [Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis]. Khirurgiia (Mosk). 1991 Sep;(9):77-81. Russian. PubMed PMID: 1721663. 5: Zurashvili BSh. [Effect of ascorutin on the thiamine level and ascorbic acid metabolism in rats subjected to exertion of various degrees of intensity]. Vopr Med Khim. 1986 Sep-Oct;32(5):53-6. Russian. PubMed PMID: 3776118. 6: Kitura EM. [Antioxidants in the prevention of meteorotropic reactions in patients with ischemic heart disease]. Klin Med (Mosk). 1985 Oct;63(10):97-9. Russian. PubMed PMID: 4079305. 7: Antiuf'ev VF, Arkhipov MV, Bychkova MA. [Use of ritmilen in disorders of cardiac rhythm]. Klin Med (Mosk). 1985 Oct;63(10):84-8. Russian. PubMed PMID: 3908802. 8: Saldan IR. [Use of disaggregants in treating diabetic retinopathy]. Oftalmol Zh. 1984;(7):395-8. Russian. PubMed PMID: 6527859.